v3.26.3
Shareholders' Equity (Deficit):
9 Months Ended
Sep. 26, 2026
Shareholders' Equity (Deficit):  
Shareholders' Equity (Deficit):

9. Shareholders’ Equity (Deficit):

​

Dividends

​

On January 28, 2026, the Company’s Board of Directors approved the payment of a $0.96 per share quarterly cash dividend to shareholders of record at the close of business on February 11, 2026, which was paid on March 2, 2026.

​

On April 15, 2026, the Company’s Board of Directors approved the payment of a $1.02 per share quarterly cash dividend to shareholders of record at the close of business on May 13, 2026, which was paid on June 1, 2026.

​

On July 15, 2026, the Company’s Board of Directors approved the payment of a $1.02 per share quarterly cash dividend to shareholders of record at the close of business on August 12, 2026, which was paid on September 1, 2026.

​

​

Repurchase of Common Stock

​

During the first nine months of 2026, the Company repurchased 33,024 shares of its common stock for an aggregate purchase price of $9.8 million. Under the Board of Directors’ authorization, as of September 26, 2026, the Company has the ability to repurchase an additional 37,632 shares of its common stock. Repurchases may be made from time to time at prevailing prices, subject to certain restrictions on volume, pricing and timing.

​

Stock Option Plans and Stock-Based Compensation

​

Stock option activity under the Company’s option plans as of September 26, 2026 was as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

​

​

  ​ ​ ​

Weighted Average

  ​ ​ ​

​

​

​

​

​

​

​

​

​

Remaining

​

​

​

​

​

Number of

​

Weighted Average

​

Contractual Life

​

​

​

​

 

Shares

 

Exercise Price

 

(years)

 

 

Intrinsic Value

Outstanding, December 27, 2025

 

315,002

​

$

238.30

​

​

​

​

​

Granted

 

32,868

​

​

377.89

​

​

​

​

​

Exercised

 

(20,358)

​

​

171.78

​

​

​

​

​

Forfeited

 

(1,866)

​

​

365.90

​

​

​

​

​

Outstanding, September 26, 2026

 

325,646

​

$

255.81

​

5.52

​

$

22,886,200

Exercisable, September 26, 2026

 

234,028

​

$

207.09

​

4.27

​

$

22,400,400

​

The fair value of options granted under the Option Plans during the first nine months of 2026 and 2025 were estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions and results:

​

​

​

​

​

​

​

​

​

​

​

​

Nine Months Ended

​

Nine Months Ended

​

​

​

  ​ ​ ​

September 26, 2026

​

September 27, 2025

​

  ​ ​ ​

Risk free interest rate

 

​

4.26

%

​

4.05

%

 

Expected life (years)

 

​

6.7

​

​

6.8

​

 

Expected volatility

 

​

28.78

%

​

29.31

%

 

Dividend yield

 

​

3.06

%

​

2.70

%

 

Option fair value

​

$

97.36

​

$

109.37

​

​

​

All unexercised options at September 26, 2026 have an exercise price equal to the fair market value on the date of the grant.

​

Compensation expense of $1,917,200 and $1,666,900 relating to the vested portion of the fair value of stock options granted was expensed to selling, general and administrative expenses in the first nine months of 2026 and 2025, respectively. As of September 26, 2026, the Company had $7.3 million of total unrecognized compensation expense related to stock options that is expected to be recognized over the remaining weighted average vesting period of approximately 3.8 years.